News Sharing
For sharing news, please enter the email address of you and the receiver, then press SEND button.*Mandatory Fields
Receiver*
Enter email addresses, separated by semicolon (;). E.g. a@a.com;b@b.com
Your email address*
 Content Sharing
HK Govt Appoints 4 New Members to Chief Executive's Council of Advisers, Including Chairmen of BIDU-SW, HENGRUI PHARMA, BIREN TECH
The HKSAR Government announced today (24th) the appointment of four new members to the Chief Executive's Council of Advisers. The term will take effect from April 1, 2026, and ...
Reset
Send
The window will close in 5 seconds
HK Govt Appoints 4 New Members to Chief Executive's Council of Advisers, Including Chairmen of BIDU-SW, HENGRUI PHARMA, BIREN TECH
Close
Recommend
18
Positive
22
Negative
18
 
SHORT SELL
 
STOCK INFO
aacat by AASTOCKS
Open a new trading account to get NVDA share!

The HKSAR Government announced today (24th) the appointment of four new members to the Chief Executive's Council of Advisers. The term will take effect from April 1, 2026, and end on June 30, 2027.

The appointees include Sun Piaoyang, Chairman of HENGRUI PHARMA (01276.HK)  -0.250 (-0.374%)    Short selling $30.73M; Ratio 25.836%   ; Xu Tao, Founder and CEO of StarFive Technology; Zhang Wen, Founder, Chairman, and CEO of BIREN TECH (06082.HK)  -2.100 (-6.646%)    Short selling $8.47M; Ratio 17.043%   ; and Robin Li, Co-founder, Chairman, and CEO of BIDU-SW (09888.HK)  -0.800 (-0.730%)    Short selling $180.79M; Ratio 150.451%   .
(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-02 16:25.)

Related News Biren Technology (06082.HK) Annual Loss Expands to RMB16.493 Billion

AASTOCKS Financial News
Copyright(C) AASTOCKS.com Limited 2000. All rights reserved.
Disclaimer: AASTOCKS.com Ltd, HKEx Information Services Limited, its holding companies and/or any subsidiaries of such holding companies endeavour to ensure the accuracy and reliability of the Information provided but do not guarantee its accuracy or reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.